372 research outputs found

    Study protocol: The Adherence and Intensification of Medications (AIM) study - a cluster randomized controlled effectiveness study

    Get PDF
    Abstract Background Many patients with diabetes have poor blood pressure (BP) control. Pharmacological therapy is the cornerstone of effective BP treatment, yet there are high rates both of poor medication adherence and failure to intensify medications. Successful medication management requires an effective partnership between providers who initiate and increase doses of effective medications and patients who adhere to the regimen. Methods In this cluster-randomized controlled effectiveness study, primary care teams within sites were randomized to a program led by a clinical pharmacist trained in motivational interviewing-based behavioral counseling approaches and authorized to make BP medication changes or to usual care. This study involved the collection of data during a 14-month intervention period in three Department of Veterans Affairs facilities and two Kaiser Permanente Northern California facilities. The clinical pharmacist was supported by clinical information systems that enabled proactive identification of, and outreach to, eligible patients identified on the basis of poor BP control and either medication refill gaps or lack of recent medication intensification. The primary outcome is the relative change in systolic blood pressure (SBP) measurements over time. Secondary outcomes are changes in Hemoglobin A1c, low-density lipoprotein cholesterol (LDL), medication adherence determined from pharmacy refill data, and medication intensification rates. Discussion Integration of the three intervention elements - proactive identification, adherence counseling and medication intensification - is essential to achieve optimal levels of control for high-risk patients. Testing the effectiveness of this intervention at the team level allows us to study the program as it would typically be implemented within a clinic setting, including how it integrates with other elements of care. Trial Registration The ClinicalTrials.gov registration number is NCT00495794.http://deepblue.lib.umich.edu/bitstream/2027.42/78258/1/1745-6215-11-95.xmlhttp://deepblue.lib.umich.edu/bitstream/2027.42/78258/2/1745-6215-11-95.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/78258/3/1745-6215-11-95-S1.DOCPeer Reviewe

    Fast Large-Tip-Angle Multidimensional and Parallel RF Pulse Design in MRI

    Full text link
    Large-tip-angle multidimensional radio-frequency (RF) pulse design is a difficult problem, due to the nonlinear response of magnetization to applied RF at large tip-angles. In parallel excitation, multidimensional RF pulse design is further complicated by the possibility for transmit field patterns to change between subjects, requiring pulses to be designed rapidly while a subject lies in the scanner. To accelerate pulse design, we introduce a fast version of the optimal control method for large-tip-angle parallel excitation. The new method is based on a novel approach to analytically linearizing the Bloch equation about a large-tip-angle RF pulse, which results in an approximate linear model for the perturbations created by adding a small-tip-angle pulse to a large-tip-angle pulse. The linear model can be evaluated rapidly using nonuniform fast Fourier transforms, and we apply it iteratively to produce a sequence of pulse updates that improve excitation accuracy. We achieve drastic reductions in design time and memory requirements compared to conventional optimal control, while producing pulses of similar accuracy. The new method can also compensate for nonidealities such as main field inhomogeneties.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/86004/1/Fessler12.pd

    The Palaeoproterozoic global carbon cycle : insights from the Loch Maree Group, NW Scotland

    Get PDF
    Fieldwork was supported by the Edinburgh Geological Society Clough & Mykura Fund, the Carnegie Undergraduate Scholarship and a stipend provided by the Irvine Bequest through the University of St Andrews to G.B.K. Laboratory work, and isotope and geochronology analyses were financed by NERC grant NE/G00398X/1 to A.R.P., A.E.F., D.J.Condon and A.P.M. Thanks go to T. Donnelly, J. Dougans, A. Calder, D. Herd, B. Pooley and A. Mackie for laboratory assistance.Peer reviewedPostprin

    Effects of Guideline and Formulary Changes on Statin Prescribing in the Veterans Affairs

    Full text link
    Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/139955/1/hesr12788-sup-0001-AppendixSA1.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/139955/2/hesr12788_am.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/139955/3/hesr12788.pd

    Parallax and Luminosity Measurements of an L Subdwarf

    Full text link
    We present the first parallax and luminosity measurements for an L subdwarf, the sdL7 2MASS J05325346+8246465. Observations conducted over three years by the USNO infrared astrometry program yield an astrometric distance of 26.7+/-1.2 pc and a proper motion of 2.6241+/-0.0018"/yr. Combined with broadband spectral and photometric measurements, we determine a luminosity of log(Lbol/Lsun) = -4.24+/-0.06 and Teff = 1730+/-90 K (the latter assuming an age of 5-10 Gyr), comparable to mid-type L field dwarfs. Comparison of the luminosity of 2MASS J05325346+8246465 to theoretical evolutionary models indicates that its mass is just below the sustained hydrogen burning limit, and is therefore a brown dwarf. Its kinematics indicate a ~110 Myr, retrograde Galactic orbit which is both eccentric (3 <~ R <~ 8.5 kpc) and extends well away from the plane (Delta_Z = +/-2 kpc), consistent with membership in the inner halo population. The relatively bright J-band magnitude of 2MASS J05325346+8246465 implies significantly reduced opacity in the 1.2 micron region, consistent with inhibited condensate formation as previously proposed. Its as yet unknown subsolar metallicity remains the primary limitation in constraining its mass; determination of both parameters would provide a powerful test of interior and evolutionary models for low-mass stars and brown dwarfs.Comment: Accepted to ApJ 10 September 2007; 13 pages, 5 figures, 3 tables, formatted in emulateapj styl

    Comparative analysis of the complete genome sequence of the California MSW strain of myxoma virus reveals potential host adaptations

    No full text
    Myxomatosis is a rapidly lethal disease of European rabbits that is caused by myxoma virus (MYXV). The introduction of a South American strain of MYXV into the European rabbit population of Australia is the classic case of host-pathogen coevolution following cross-species transmission. The most virulent strains of MYXV for European rabbits are the Californian viruses, found in the Pacific states of the United States and the Baja Peninsula, Mexico. The natural host of Californian MYXV is the brush rabbit, Sylvilagus bachmani. We determined the complete sequence of the MSW strain of Californian MYXV and performed a comparative analysis with other MYXV genomes. The MSW genome is larger than that of the South American Lausanne (type) strain of MYXV due to an expansion of the terminal inverted repeats (TIRs) of the genome, with duplication of the M156R, M154L, M153R, M152R, and M151R genes and part of the M150R gene from the right-hand (RH) end of the genome at the left-hand (LH) TIR. Despite the extreme virulence of MSW, no novel genes were identified; five genes were disrupted by multiple indels or mutations to the ATG start codon, including two genes, M008.1L/R and M152R, with major virulence functions in European rabbits, and a sixth gene, M000.5L/R, was absent. The loss of these gene functions suggests that S. bachmani is a relatively recent host for MYXV and that duplication of virulence genes in the TIRs, gene loss, or sequence variation in other genes can compensate for the loss of M008.1L/R and M152R in infections of European rabbits.This work was funded in part by grant R01 AI093804 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health. E.C.H. was supported by an NHMRC Australia Fellowship, and D.C.T. was supported by an ARC Future Fellowship
    • 

    corecore